文献速递肝胆胰外科围术期管理与 ERAS

胰腺切除术后再入院危险因素:全国性队列研究

Study of Risk Factors for Readmission After Pancreatectomy for Cancer: Analysis of Nationwide Cohort.
PubMed 文献 · Ann Surg · 2023-05-31

基于法国2011至2019年全国医疗行政数据库,纳入22,935例因癌症行胰腺切除术的患者,分析再入院相关因素及其对1年死亡率的影响。结果显示39.3%的患者在6个月内再入院,男性、年龄>70岁、合并症、远端胰腺切除及术后重大并发症为再入院预测因素;再入院和低容量中心手术分别使1年死亡风险增加2.15倍和1.31倍。

要点

  • 胰腺癌切除术后6个月内再入院率高达39.3%,再入院使1年死亡风险增加2.15倍。
  • 男性、年龄>70岁、合并症、远端胰腺切除及术后重大并发症是再入院的独立预测因素。
  • 低容量中心(≤26例/年)手术使1年死亡风险增加1.31倍,再入院平均发生在出院后20天内。

核心结论

  • 胰腺癌切除术后再入院率高,且再入院与1年死亡率增加独立相关。

研究设计与样本

  • 基于法国国家医疗行政数据库的回顾性多中心队列研究,纳入2011至2019年因癌症行胰腺切除术的22,935例患者。

主要发现

  • 22,935例患者中9,129例(39.3%)在6个月内再入院,再入院率在研究期间无年度变化,平均再入院时间为出院后20天内。
  • 多因素分析显示男性(OR=1.12)、年龄>70岁(OR=1.16)、合并症(OR=1.21)、远端胰腺切除(OR=1.11)及术后重大并发症(OR=1.37)为再入院的预测因素。

关键数值与推荐

  • 中心容量以26例/年为界分为低容量和高容量中心。

临床怎么用

  • 对具有男性、年龄>70岁、合并症、远端胰腺切除及术后重大并发症等危险因素的患者,应加强出院后早期(20天内)随访和干预,以降低再入院风险。
  • 应关注低容量中心(≤26例/年)的胰腺切除术预后,优化围术期管理以改善1年生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify the factors associated with readmission after pancreatectomy for cancer and to assess their impact on the 1-year mortality in a French multicentric population. BACKGROUND: Pancreatectomy is a complex procedure with high morbidity that increases the length of hospital stay and jeopardizes survival. Hospital readmissions lead to increased health system costs, making this a topic of great interest. METHODS: Data collected from patients who underwent pancreatectomy for cancer between 2011 and 2019 were extracted from a French national medico-administrative database. A descriptive analysis was conducted to evaluate the association of baseline variables, including age, sex, liver-related comorbidities, Charlson Comorbidity Index, tumor localization, and use of neoadjuvant therapy, along with hospital type and volume, with readmission status. Centers were divided into low and high volumes according to the cutoff of 26 cases/year. Logistic regression models were developed to determine whether the identified bivariate associations persisted after adjusting for the patient characteristics. The mortality rates during readmission and at 1 year postoperatively were also determined. RESULTS: Of 22,935 patients who underwent pancreatectomy, 9129 (39.3%) were readmitted within 6 months. Readmission rates by year did not vary over the study period, and mean readmissions occurred within 20 days after discharge. Multivariate analysis showed that male sex [odds ratio (OR) = 1.12], age >70 years (OR = 1.16), comorbidities (OR = 1.21), distal pancreatectomy (OR = 1.11), and major postoperative complications (OR = 1.37) were predictors of readmission. Interestingly, readmission and surgery in low-volume centers increased the risk of death at 1 year by a factor of 2.15 [(2.01-2.31), P < 0.001] and 1.31 [(1.17-1.47), P < 0.001], respectively. CONCLUSIONS: Readmission after pancreatectomy for cancer is high with an increased rate of 1-year mortality.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Marchese U, Desbiens JF, Lenne X, et al. Study of Risk Factors for Readmission After Pancreatectomy for Cancer: Analysis of Nationwide Cohort. Ann Surg. 2023. PMID: 37254769. doi:10.1097/SLA.0000000000005929

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。